Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

CV Therapeutics

CV Therapeutics?uq=hBqTzBbB
1990 FOUNDED
M&A STATUS
801-900 EMPLOYEES
M&A LATEST DEAL TYPE
$1.4B LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer and marketer of novel, small molecule drugs for the treatment of cardiovascular diseases. The company's major products were Ranexa (ranolazine extended-release tablets) and Lexiscan (regadenoson).

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 3172 Porter Dr
  • Palo Alto, CA 94304
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore CV Therapeutics’s full profile, request a free trial.

CV Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 17-Apr-2009 $1.4B 00000 00.00 Completed Generating Revenue
8. PIPE 16-Apr-2008 00000 00000 Completed Generating Revenue
7. PIPE 18-Apr-2006 00000 00000 Completed Generating Revenue
6. PIPE 01-Aug-2000 00000 00000 Completed Generating Revenue
5. IPO 06-Oct-1999 0000 00000 Completed Generating Revenue
4. Later Stage VC (Series G) 01-May-1996 000.00 000.00 Completed Generating Revenue
3. Later Stage VC (Series E) 01-Nov-1995 00.000 000.00 Completed Generating Revenue
2. Later Stage VC (Series D) 01-Apr-1994 $16.5M $23.4M Completed Generating Revenue
1. Later Stage VC (Series C) 01-Jul-1993 $6.88M $6.88M Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

CV Therapeutics Former Investors (15)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Acqua Wellington PE/Buyout Minority 000 0000 000000 0
Alloy Ventures Venture Capital Minority 000 0000 000000 0
Asset Management Ventures Venture Capital Minority 000 0000 000000 0
Banexi Ventures Partners Venture Capital Minority 000 0000 000000 0
CHL Medical Partners Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 15 investors. Get the full list »